387 related articles for article (PubMed ID: 33529580)
1. Using high sensitivity cardiac troponin values in patients with SARS-CoV-2 infection (COVID-19): The Padova experience.
De Michieli L; Babuin L; Vigolo S; Berti De Marinis G; Lunardon A; Favretto F; Lobo R; Sandoval Y; Bryant SC; Donato D; Plebani M; Vettor R; Iliceto S; Cianci V; Jaffe AS
Clin Biochem; 2021 Apr; 90():8-14. PubMed ID: 33529580
[TBL] [Abstract][Full Text] [Related]
2. Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease.
Cao J; Zheng Y; Luo Z; Mei Z; Yao Y; Liu Z; Liang C; Yang H; Song Y; Yu K; Gao Y; Zhu C; Huang Z; Qian J; Ge J
Theranostics; 2020; 10(21):9663-9673. PubMed ID: 32863952
[No Abstract] [Full Text] [Related]
3. No increase in the incidence of cardiac troponin I concentration above the 99th percentile by Siemens Centaur high-sensitivity compared to the contemporary assay.
Yang HS; Shemesh A; Li J; Xie T; Apple FS; Williams J; Zhao Z; Steel PAD
Clin Biochem; 2021 Mar; 89():77-80. PubMed ID: 33296707
[TBL] [Abstract][Full Text] [Related]
4. High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19.
De Michieli L; Ola O; Knott JD; Akula A; Mehta RA; Hodge DO; Dworak M; Yang EH; Gharacholou M; Singh G; Singh R; Gulati R; Jaffe AS; Sandoval Y
Clin Chem; 2021 Aug; 67(8):1080-1089. PubMed ID: 33860295
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
[TBL] [Abstract][Full Text] [Related]
6. Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency department.
Kavsak PA; Neumann JT; Cullen L; Than M; Shortt C; Greenslade JH; Pickering JW; Ojeda F; Ma J; Clayton N; Sherbino J; Hill SA; McQueen M; Westermann D; Sörensen NA; Parsonage WA; Griffith L; Mehta SR; Devereaux PJ; Richards M; Troughton R; Pemberton C; Aldous S; Blankenberg S; Worster A
CMAJ; 2018 Aug; 190(33):E974-E984. PubMed ID: 30127037
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system.
Sandoval Y; Smith SW; Schulz KM; Murakami MM; Love SA; Nicholson J; Apple FS
Clin Chem; 2015 Apr; 61(4):657-63. PubMed ID: 25672334
[TBL] [Abstract][Full Text] [Related]
8. Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin.
Kaufmann CC; Ahmed A; Kassem M; Freynhofer MK; Jäger B; Aicher G; Equiluz-Bruck S; Spiel AO; Vafai-Tabrizi F; Gschwantler M; Fasching P; Wojta J; Giannitsis E; Huber K
Clin Res Cardiol; 2022 Mar; 111(3):343-354. PubMed ID: 34782921
[TBL] [Abstract][Full Text] [Related]
9. Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I.
Boeddinghaus J; Nestelberger T; Koechlin L; Wussler D; Lopez-Ayala P; Walter JE; Troester V; Ratmann PD; Seidel F; Zimmermann T; Badertscher P; Wildi K; Rubini Giménez M; Potlukova E; Strebel I; Freese M; Miró Ò; Martin-Sanchez FJ; Kawecki D; Keller DI; Gualandro DM; Christ M; Twerenbold R; Mueller C;
J Am Coll Cardiol; 2020 Mar; 75(10):1111-1124. PubMed ID: 32164884
[TBL] [Abstract][Full Text] [Related]
10. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19.
Stefanini GG; Chiarito M; Ferrante G; Cannata F; Azzolini E; Viggiani G; De Marco A; Briani M; Bocciolone M; Bragato R; Corrada E; Gasparini GL; Marconi M; Monti L; Pagnotta PA; Panico C; Pini D; Regazzoli D; My I; Kallikourdis M; Ciccarelli M; Badalamenti S; Aghemo A; Reimers B; Condorelli G;
Heart; 2020 Oct; 106(19):1512-1518. PubMed ID: 32817312
[TBL] [Abstract][Full Text] [Related]
11. Validation of presentation and 3 h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction.
Pickering JW; Greenslade JH; Cullen L; Flaws D; Parsonage W; George P; Worster A; Kavsak PA; Than MP
Heart; 2016 Aug; 102(16):1270-8. PubMed ID: 26955848
[TBL] [Abstract][Full Text] [Related]
12. Association between cardiac troponin I and mortality in patients with COVID-19.
Salvatici M; Barbieri B; Cioffi SMG; Morenghi E; Leone FP; Maura F; Moriello G; Sandri MT
Biomarkers; 2020 Dec; 25(8):634-640. PubMed ID: 33003961
[TBL] [Abstract][Full Text] [Related]
13. Suspected myocardial infarction in the emergency department: An evaluation of clinical thresholds for the Beckman Coulter Access hsTnI high-sensitivity cardiac troponin I assay.
Meek R; Cullen L; Lu Z; Nasis A; Kuhn L; Sorace L
Emerg Med Australas; 2023 Dec; 35(6):1005-1012. PubMed ID: 37442553
[TBL] [Abstract][Full Text] [Related]
14. Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I.
Sandoval Y; Nowak R; deFilippi CR; Christenson RH; Peacock WF; McCord J; Limkakeng AT; Sexter A; Apple FS
J Am Coll Cardiol; 2019 Jul; 74(3):271-282. PubMed ID: 31319909
[TBL] [Abstract][Full Text] [Related]
15. Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin.
Boeddinghaus J; Reichlin T; Nestelberger T; Twerenbold R; Meili Y; Wildi K; Hillinger P; Giménez MR; Cupa J; Schumacher L; Schubera M; Badertscher P; Corbière S; Grimm K; Puelacher C; Sabti Z; Widmer DF; Schaerli N; Kozhuharov N; Shrestha S; Bürge T; Mächler P; Büchi M; Rentsch K; Miró Ò; López B; Martin-Sanchez FJ; Rodriguez-Adrada E; Morawiec B; Kawecki D; Ganovská E; Parenica J; Lohrmann J; Buser A; Keller DI; Osswald S; Mueller C
Clin Res Cardiol; 2017 Jun; 106(6):457-467. PubMed ID: 28150185
[TBL] [Abstract][Full Text] [Related]
16. The utility of presentation and 4-hour high sensitivity troponin I to rule-out acute myocardial infarction in the emergency department.
Pickering JW; Young JM; George P; Aldous S; Cullen L; Greenslade JH; Richards AM; Troughton R; Ardagh M; Frampton CM; Than MP
Clin Biochem; 2015 Dec; 48(18):1219-24. PubMed ID: 26232285
[TBL] [Abstract][Full Text] [Related]
17. Single test rule-out of acute myocardial infarction using the limit of detection of a new high-sensitivity troponin I assay.
Body R; Morris N; Collinson P
Clin Biochem; 2020 Apr; 78():4-9. PubMed ID: 32135083
[TBL] [Abstract][Full Text] [Related]
18. Single High-Sensitivity Cardiac Troponin I to Rule Out Acute Myocardial Infarction.
Sandoval Y; Smith SW; Love SA; Sexter A; Schulz K; Apple FS
Am J Med; 2017 Sep; 130(9):1076-1083.e1. PubMed ID: 28344141
[TBL] [Abstract][Full Text] [Related]
19. The absolute and relative changes in high-sensitivity cardiac troponin I are associated with the in-hospital mortality of patients with fulminant myocarditis.
Liu C; Wang Z; Chen K; Cui G; Chen C; Wang L; Jiang J
BMC Cardiovasc Disord; 2021 Nov; 21(1):571. PubMed ID: 34847863
[TBL] [Abstract][Full Text] [Related]
20. Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients.
Lorente-Ros A; Monteagudo Ruiz JM; Rincón LM; Ortega Pérez R; Rivas S; Martínez-Moya R; Sanromán MA; Manzano L; Alonso GL; Ibáñez B; Zamorano JL
Cardiol J; 2020; 27(5):489-496. PubMed ID: 32589258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
